Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
Saved in:
| Published in: | Neuropsychopharmacology Reports |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Clopidogrel, an ADP‐P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan
- Shared effects of the opioid antagonist naltrexone on first-hand and empathic pain
- Pharmacological Incongruity of Lacosamide in the Management of Delirium Complicated by Ileus
- Development and Validation of a Prediction Model for Postoperative Delirium
- Persistent Delirium in the Elderly: A Case Report and Review of Multifactorial Contributors and Management Challenges
- Evolving Trends and Collaborative Networks in Postoperative Delirium Research: A Two‐Decade Bibliometric Analysis
- An Unusual Case of Multifactorial Catatonia Following Taxane-Based Chemotherapy Regimen